Health
Novo Nordisk's GLP‑1 RA--A Modern Treatment for Obesity Management--is Linked to Lower Household Spending on Alcohol and Tobacco
At the international scientific congress ObesityWeek® held late last year in Atlanta, United States, Novo Nordisk presented findings from a real-world analysis of grocery spending data from more than 200,000 households.[1] The analysis found that households with at least one person using Novo Nordisk's GLP‑1 RA for weight management showed a year-on-year reduction in overall grocery spending compared with households not using similar medicines—most notably in purchases of alcohol and tobacco/cig
About this update from Novo Nordisk A/s Class B
[{"type":"text","content":"Real-world data analysis suggests that families with at least one member using Novo Nordisk's GLP‑1 RA for weight management tend to reduce spending on alcohol and cigarettes.","length":179,"tagName":"p","attribs":{}},{"type":"text","content":"JAKARTA, Indonesia, Jan. 12, 2026 /PRNewswire/ -- At the international scientific congress ObesityWeek® held late last year in Atlanta, United States, Novo Nordisk presented findings from a real-world analysis of grocery spending data from more than 200,000 households.[1] The analysis found that households with at least one person using Novo Nordisk's GLP‑1 RA for weight management showed a year-on-year reduction in overall grocery spending compared with households not using similar medicines—most notably in purchases of alcohol and tobacco/cigarette products.","length":575,"tagName":"p"},{"type":"text","content":"These findings indicate a potential association between the use of Novo Nordisk's GLP‑1 medicine for weight management and reduced alcohol and tobacco consumption at the household level.","length":190,"tagName":"p"},{"type":"text","content":"In Indonesia, obesity is becoming an increasingly concerning health issue. Based on the latest national health survey, the number of adults living with obesity and excess abdominal fat continues to rise. In simple terms, it is currently estimated that around 1 in 4 adults in Indonesia live with obesity or carry excess fat around the waist. Obesity is not just about appearance—people living with obesity face a higher risk of type 2 diabetes, high blood pressure, heart disease, stroke, and joint pain, which can affect quality of life and increase the financial burden on families.","length":584,"tagName":"p"},{"type":"text","content":"In this analysis, researchers assessed household spending data on daily groceries across two 12‑month periods. Data were collected through recurring surveys between April 2024 and April 2025 from a large consumer panel that recorded shopping receipts and completed surveys on household information, medicine use, and habits. Results showed that households with at least one user of Novo Nordisk's GLP‑1 RA for weight management experienced a year-on-year reduction in grocery spending, driven mainly by lower spending on alcohol and tobacco/cigarette products, compared with households without a GLP‑1...